Why TherapeuticsMD Inc. (TXMD)’s Most Recent Report Reveals Some Hints About Its Future – News Heater
Home  »  Business   »  Why TherapeuticsMD Inc. (TXMD)’s Most Recent Rep...

Why TherapeuticsMD Inc. (TXMD)’s Most Recent Report Reveals Some Hints About Its Future

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

TherapeuticsMD Inc. (NASDAQ:TXMD) went down by -3.60% from its latest closing price compared to the recent 1-year high of $2.75. The company’s stock price has collected 7.20% of gains in the last five trading sessions. Press Release reported on 05/25/21 that TherapeuticsMD Announces Submission of Low Dose BIJUVA(R) 0.5 mg/100 mg Supplemental New Drug Application to FDA

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in TherapeuticsMD Inc. (NASDAQ :TXMD) Right Now?

Plus, the 36-month beta value for TXMD is at 1.91. Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for TherapeuticsMD Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



The average price from analysts is $5.20. TXMD currently public float of 361.91M and currently shorts hold a 17.14% ratio of that float. Today, the average trading volume of TXMD was 8.81M shares.

TXMD’s Market Performance

TXMD stocks went up by 7.20% for the week, with a monthly jump of 28.85% and a quarterly performance of -15.72%, while its annual performance rate touched -0.74%. The volatility ratio for the week stands at 6.14% while the volatility levels for the past 30 days are set at 5.87% for TherapeuticsMD Inc.. The simple moving average for the period of the last 20 days is 12.13% for TXMD stocks with a simple moving average of -4.02% for the last 200 days.

TXMD Trading at 10.79% from the 50-Day Moving Average

After a stumble in the market that brought TXMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.27% of loss for the given period.

Volatility was left at 5.87%, however, over the last 30 days, the volatility rate increased by 6.14%, as shares surge +31.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading unchanged at present.

During the last 5 trading sessions, TXMD rose by +7.20%, which changed the moving average for the period of 200-days by -14.65% in comparison to the 20-day moving average, which settled at $1.2110. In addition, TherapeuticsMD Inc. saw 10.74% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TXMD starting from Thompson Tommy G, who purchase 5,000 shares at the price of $1.06 back on May 14. After this action, Thompson Tommy G now owns 704,600 shares of TherapeuticsMD Inc., valued at $5,300 using the latest closing price.

Donegan Michael C, the CAO and VP Finance of TherapeuticsMD Inc., sale 4,842 shares at $1.04 during a trade that took place back on May 11, which means that Donegan Michael C is holding 14,158 shares at $5,036 based on the most recent closing price.

Stock Fundamentals for TXMD

Current profitability levels for the company are sitting at:

  • -239.76 for the present operating margin
  • +73.77 for the gross margin

The net margin for TherapeuticsMD Inc. stands at -282.90. The total capital return value is set at -91.74, while invested capital returns managed to touch -109.45. Equity return is now at value 193.30, with -82.60 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 7.73, with the company’s debt to enterprise value settled at 0.50. The receivables turnover for the company is 2.29 and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.17.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

A Lesson to Learn: 2U Inc. (TWOU)

2U Inc. (NASDAQ:TWOU) went up by 3.89% from its latest closing price compared to the recent 1-year high of $59.74. The company’s stock price has

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.